At Trump's request, India last month allowed the export of 50 million HCQ tablets to treat COVID-19 patients Washington: Several hospitals in the US are using the antimalarial drug hydroxychloroquine as the first-line of therapy for COVID-19 positive patients, a medical publication has reported.
MDedge on Friday reported that hydroxychloroquine (HCQ) is currently the first-line therapy and Tocilizumab the second-line medication for people hospitalised with polymerase chain reaction-confirmed COVID-19 infection in the Yale New Haven Health System, which operates hospitals across Connecticut, one of the hotspots in the US.